Optimizing Maternal and Neonatal Health: Strategies for Screening, Diagnosing, and Treating Substance Use Disorders in Pregnancy
This 1-hour training focuses on actionable strategies for screening, diagnosing, and treating substance use disorder in pregnancy.
Optimizing Maternal and Neonatal Health: Strategies for Screening, Diagnosing, and Treating Substance Use Disorders in Pregnancy
Meets DEA training requirements
1.0 AMA PRA Category 1 Credit(s)™
Learning objectives:
- Recognize the prevalence of substance use and substance use disorders during pregnancy and identify their association with obstetric and neonatal adverse outcomes.
- Develop a comprehensive understanding of the recommended screening protocols for substance use in pregnant patients to ensure early identification and intervention.
- Explore evidence-based treatment strategies and management plans for pregnant patients with substance use disorders to minimize morbidity and mortality risks for both the mother and neonate.
Accreditation and Credit Designation
Accreditation Council for Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MyMichigan Health and OPEN. MyMichigan Health is accredited by the Michigan State Medical Society (MSMS) to provide continuing medical education for physicians. MyMichigan Health designates this live activity for a maximum of 1 AMA PRA Category Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.